| People | Locations | Statistics |
|---|---|---|
| Naji, M. |
| |
| Motta, Antonella |
| |
| Aletan, Dirar |
| |
| Mohamed, Tarek |
| |
| Ertürk, Emre |
| |
| Taccardi, Nicola |
| |
| Kononenko, Denys |
| |
| Petrov, R. H. | Madrid |
|
| Alshaaer, Mazen | Brussels |
|
| Bih, L. |
| |
| Casati, R. |
| |
| Muller, Hermance |
| |
| Kočí, Jan | Prague |
|
| Šuljagić, Marija |
| |
| Kalteremidou, Kalliopi-Artemi | Brussels |
|
| Azam, Siraj |
| |
| Ospanova, Alyiya |
| |
| Blanpain, Bart |
| |
| Ali, M. A. |
| |
| Popa, V. |
| |
| Rančić, M. |
| |
| Ollier, Nadège |
| |
| Azevedo, Nuno Monteiro |
| |
| Landes, Michael |
| |
| Rignanese, Gian-Marco |
|
Mautner, Franz A.
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (18/18 displayed)
- 2023Dinuclear doubly bridged phenoxido copper(II) complexes as efficient anticancer agentscitations
- 2023Structure and magnetic characterization of some bicompartmental [N6O2] divalent metal(ii) complexes using bis(phenolato) ligands bearing two pendant bis(pyridyl) amine arms
- 2023Magnetostructural Properties of Some Doubly-Bridged Phenoxido Copper(II) Complexescitations
- 2023Copper(II) and zinc(II) complexes bridged by benzenoid aromatic oxocarbon and dicarboxylate dianionscitations
- 2021Synthesis, crystal structures, spectral, magnetic and thermal properties of 1-D polymeric dicyanamido-metal(II) complexescitations
- 2021Identification of potent anticancer copper(ii) complexes containing tripodal bis[2-ethyl-di(3,5-dialkyl-1H-pyrazol-1-yl)]amine moietycitations
- 2021Syntheses, structural characterization, and thermal behaviour of metal complexes with 3-aminopyridine as co-ligandscitations
- 2019Thiocyanato-metal(II) and azido-cobalt(III) complexes with hydroxymethylpyridinescitations
- 2017Synthesis, structural characterization and magnetic properties of polymeric azido Mn(II) complexes based on methyl-pyridine-N-oxide co-ligandscitations
- 2017Pyridyl and triazole ligands directing the assembling of zinc(II) into coordination polymers with different dimensionality through azides.citations
- 2016Metal(II) complexes of compartmental polynuclear schiff bases containing phenolate and alkoxy groups.citations
- 2016Synthesis, characterization and luminescence properties of zinc(II) and cadmium(II) pseudohalide complexes derived from quinoline-N-oxide.citations
- 2015Influence of co-ligands in synthesis, photoluminescence behavior and catalytic activities of zinc complexes of 2-((E)-((pyridin-2-yl)methylimino)methyl)phenol.citations
- 2015Magnetic and structural properties of dinuclear singly bridged-phenoxido metal(II) complexes.citations
- 2015Synthesis, characterization and luminescence properties of zinc(II) complexes of pseudohalides and nitrite derived from 4-azidopyridinecitations
- 2015Synthesis and characterization of three new 1-D polymeric [M2(4-azidopyridine)4(μ1,1-N3)2(μ1,3-N3)2]n (M = Ni, Co, Cd) complexes.citations
- 2015Five-coordinate metal(II) complexes based pyrazolyl ligands.citations
- 2015Synthesis and characterization of five new thiocyanato- and cyanato-metal(II) complexes with 4-azidopyridine as co-ligandcitations
Places of action
| Organizations | Location | People |
|---|
article
Identification of potent anticancer copper(ii) complexes containing tripodal bis[2-ethyl-di(3,5-dialkyl-1H-pyrazol-1-yl)]amine moiety
Abstract
<p>A series of heteroleptic copper(ii) complexes of the composition [Cu(L1-5)Cl]X, where X = ClO4 and/or PF6 and [bis(2-ethyl-di(3,5-dimethyl-1H-pyrazol-1-yl))-(6-methyl-(2-pyridylmethyl))]amine (L1), [bis(2-ethyl-di(3,5-dimethyl-1H-pyrazol-1-yl))-(3,4-dimethoxy-(2-pyridylmethyl))]amine (L2), [bis(2-ethyl-di(3,5-dimethyl-1H-pyrazol-1-yl)-(2-quinolymethyl)]amine (L3), [bis(2-ethyl-di(3,5-dimethyl-1H-pyrazolyl)-(di(3,5-dimethyl-1H-pyrazol-1-yl-methyl))]amine (L4) and [bis(2-ethyl-di(3,5-dimethyl-1H-pyrazol-1-yl)-(5-methyl-3-phenyl-1H-pyrazol-1-yl-methyl)]amine (L5), were prepared and thoroughly characterized including single-crystal X-ray diffraction technique. The in vitro cytotoxicity of complexes against A2780, A2780R, HOS and MCF-7 human cancer cell lines was evaluated using the MTT test. The results revealed that complexes [Cu(L1)Cl]PF6 (1-PF6), [Cu(L2)Cl]ClO4 (2-ClO4) and [Cu(L3)Cl]PF6 (3-PF6) are the most effective, with IC50 values ranging from 1.4 to 6.3 μM, thus exceeding the cytotoxic potential of metallodrug cisplatin (IC50 values ranging from 29.9 to 82.0 μM). The complexes [Cu(L4)Cl]PF6 (4-PF6) and [Cu(L5)Cl]PF6 (5-PF6) showed only moderate cytotoxicity against A2780, with IC50 = 53.6 μM, and 33.8 μM, respectively. The cell cycle profile, time-resolved cellular uptake, interactions with small sulfur-containing biomolecules (cysteine and glutathione), intracellular ROS production, induction of apoptosis and activation of caspases 3/7 were also evaluated in the case of the selected complexes. It has been found that the best performing complexes 1 and 2 cause cell arrest in the G2/M phase and induce apoptosis via the increase in production of ROS, dominantly due to the overproduction of superoxide.</p>